We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
- Authors
van Leeuwen, F E; Chorus, A M; van den Belt-Dusebout, A W; Hagenbeek, A; Noyon, R; van Kerkhoff, E H; Pinedo, H M; Somers, R
- Abstract
The development of leukemia is one of the most serious long-term complications of modern treatment for Hodgkin's disease (HD). This study was undertaken to examine the relation between risk of leukemia and various treatment factors (including cumulative dose of cytostatic drugs and interaction with radiotherapy [RT]), while also assessing the effect of treatment-induced bone marrow damage.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Vol 12, Issue 5, p1063
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1994.12.5.1063